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ABSTRACT
Methods for the detection of m6A by RNA-Seq tech-
nologies are increasingly sought after. We here
present NOseq, a method to detect m6A residues
in defined amplicons by virtue of their resistance
to chemical deamination, effected by nitrous acid.
Partial deamination in NOseq affects all exocyclic
amino groups present in nucleobases and thus also
changes sequence information. The method uses a
mapping algorithm specifically adapted to the se-
quence degeneration caused by deamination events.
Thus, m6A sites with partial modification levels of
∼50% were detected in defined amplicons, and this
threshold can be lowered to ∼10% by combination
with m6A immunoprecipitation. NOseq faithfully de-
tected known m6A sites in human rRNA, and the
long non-coding RNA MALAT1, and positively vali-
dated several m6A candidate sites, drawn from mi-
CLIP data with an m6A antibody, in the transcrip-
tome of Drosophila melanogaster. Conceptually re-
lated to bisulfite sequencing, NOseq presents a novel
amplicon-based sequencing approach for the valida-
tion of m6A sites in defined sequences.
INTRODUCTION
The occurrence of m6A in eukaryotic polyadenylated RNA
is among the most investigated phenomena in recent RNA
research. As we now know, m6A deposition on nascent
RNA is an early and important event in maturation of
mRNA, which is orchestrated by a sophisticated catalytic
complex, whose components are subject to continuous up-
dates (1–3). Methylation of adenosines has been shown to
be important for regulation of downstream events including
splicing (4), transport (5,6), degradation (7) and translation
(8). Variegated amounts or lack of m6A have been associ-
ated with numerous pathologies (9–12), and impact in in-
fection biology is a much-investigated aspect (13,14). The
presence of m6A in mRNA has been known for decades
(15–17), pioneered about 50 years ago by analytical tech-
niques that are still widely used, namely isolation of mRNA
by hybridization to poly(dT)-cellulose (18,19) or poly(U)-
sepharose (20) and enrichment of m6A-containing RNA us-
ing antibodies (21,22). Breakthrough papers in 2012 (23,24)
combined this approach with deep sequencing to create the
first m6A maps of what is now termed the ‘epitranscrip-
tome’ (25), thus creating a boost of the field that is still un-
abated (26,27). However, the community is in agreement,
that the use of antibodies alone, or in refining combinations
with other techniques (15–17), still does not provide quan-
titative data at single nucleotide resolution (28). Numerous
tools from chemical biology have been applied to the task,
including catalytic DNA (29), chemically altered dNTPs
(30), engineered SAM analogues (31) or engineered poly-
merases (32) for the generation of a reverse transcription
signature, or derivatives of SAM or metabolic precursor me-
thionine (33) for click chemistry-based enrichment. Current
developments focus on the use of nanopore technology (34),
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m6A-discriminating nucleases (35–37) and fusion proteins
for RNA-editing adjacent to m6A sites (38,39). Despite
these developments, a technology that resembles the bisul-
fite sequencing of m5C in terms of resolution and quantifi-
cation is not yet in sight. Taking a clue from the chemistry of
bisulfite sequencing (40–42), we examined the possibility of
a reagent that would deaminate adenosines to inosine (I),
and thus change its sequencing properties, while differen-
tially reacting with m6A such as to not alter its reverse tran-
scription signal. While adenosines are largely inert to nucle-
ophiles like bisulfite, we found reports on adenosine deami-
nation by nitrous acid (43), which led to the characterization
of N6-methyl-N6-nitrosoadenosine (NOm6A) (44) (Figure
1A), with unknown base-pairing properties. For a targeted
site-specific investigation of modified nucleotides in biolog-
ical templates, a common methodology is the amplification
of sequence regions. By applying primers to define sequence
contexts, amplicon libraries for deep sequencing can be pre-
pared and subsequently analysed (45).
Here, we present NOseq, an Illumina sequencing-based
analysis pipeline for deaminated RNA sequences and m6A
site detection by amplicon sequencing. The workflow com-
bines an optimized deamination protocol, target-specific li-
brary preparation and a deamination-related alignment al-
gorithm. The latter is based on the well-known seed-and-
extend mapping strategy, first introduced in Blast (46) and
mostly used by short read analysis tools (47) as SOAP (48)
and BOWTIE (49). The algorithm principle stands on the
extension and selection of matching k-mers (short sequence
of k bases) between reads and references. Basically, an align-
ment score is attributed according to a substitution matrix,
taking mismatches and gaps into account. Here, we im-
plemented an asymmetric substitution matrix considering
deamination-induced nucleotide conversion, an alignment
strategy known from bisulfite sequencing (e.g. BSMAP
(50)). We successfully recapitulated known m6A sites in hu-
man MALAT1 lncRNA, human 18S rRNA and validated
new m6A sites in mRNA Hairless (H) and female-lethal-2-d
(fl(2)d) from Drosophila melanogaster.
MATERIALS AND METHODS
RNA preparation
Total RNA extraction from HEK and HeLa cells. HEK293
or HeLa cells were cultured at 37◦C with 5% CO2 in T-
160 cell culture flasks containing growth medium (90% D-
MEM, 10% FBS and 1% Pen/Strep). Cultures at around
80% confluency were routinely splitted, i.e. every 24–48 h
in new growth medium until harvesting of the cells and
up to 1 month (10 passages). For total RNA extraction,
cells were detached from the flasks for 5 min with 3 ml of
Trypsin/EDTA (Sigma-Aldrich) and pelleted by low speed
centrifugation in a 50 ml tube. The cells at confluency were
evaluated (seeding) at ∼18 million, resuspended and vor-
texed in 2 ml TriReagent (Sigma Aldrich) before adding
800 l of chloroform allowing phase separation under cen-
trifugation (12 000 × g, 4◦C, 15 min). The upper aque-
ous phase containing RNA was precipitated with 250 l
of 100% nuclease-free isopropanol. After vortexing, incuba-
tion and centrifugation (15 000 × g, 4◦C, 10 min), the pellet
was washed twice with 80% ethanol, centrifuged again and
the air-dried pellet was finally dissolved in MilliQ water.
PolyA RNA extraction from Drosophila melanogaster.
Drosophila melanogaster Oregon-R wild-type strain and
Ime4null knockout strain (51) were maintained at 25◦C, at
standard conditions. For total RNA isolation, 20 flies were
smashed together per 1.5 ml tube with 100 l TriReagent
(Sigma Aldrich) before adding another 400 l and incubat-
ing the mixture at 4◦C for 5 min. After adding 100 l chlo-
roform and vortexing for 15 s, an incubation step at 4◦C
for 10 min was followed by centrifugation (12 000 × g, 4◦C,
15 min), permitting phase separation. The upper aqueous
phase was kept for total RNA precipitation by adding 250
l of 100% nuclease-free isopropanol. After centrifugation
(15 000 × g, 4◦C, 10 min), the RNA pellet was washed twice
with 750 l 80% ethanol and centrifuged again. Ethanol
was then removed, and the pellet air-dried for 5 min at room
temperature. The pellet was finally dissolved in MilliQ wa-
ter and quantified. For polyA RNA extraction, 60 g of
total RNA were first treated with DNase I (Thermo Scien-
tific) to avoid DNA contamination before incubation with
100 l washed oligo d(T)25 magnetic beads (New England
Biolabs), to isolate mRNA from total RNA according to
a modified protocol of Dynabeads (Thermo Scientific), in-
cluding a second round of purification and elution in MilliQ
water.
RNA quantification and quality control. RNA was quan-
tified using the UV-Vis spectrophotometer Nanodrop 2000
(Thermo Scientific) and the purity was assessed according
to both absorption ratios A260/A280 and A260/A230 respec-
tively in the range of 2 and 1.8–2.2 reflecting contaminant
free samples. Isolated total RNA and mRNA were anal-
ysed, and quality evaluation by automated electrophoresis
on the Agilent 4200 TapeStation system, following RNA
ScreenTape Assay instructions, was performed.
Methylated RNA immunoprecipitation (MeRIP). The
anti-m6A monoclonal mouse antibody (purified IgG)
(Synaptic Systems) was first incubated overnight at 4◦C in
1× PBS with Protein G Sepharose 4 Fast Flow antibody
purification resin (GE Healthcare). Around 8 g of total
RNA, mRNA or synthetic oligonucleotide (Table 1) were
added to the binding buffer after several antibody-beads
washing steps and kept for 2 h incubation at 4◦C and un-
der shaking. This incubation step was repeated, including
the washing steps, together with the addition of 0.5 mg/ml
adenosine (Sigma-Aldrich) in order to induce a competitive
elution of non-targeted RNA. Targeted m6A RNA frag-
ments were then isolated from the antibodies by TriReagent
(Sigma Aldrich) and following ethanol precipitation.
Deamination
Deamination with sodium nitrite. RNA
(synthetic/isolated/immunoprecipitated) was deaminated
under different conditions. Reactions were performed in
a total volume of 100 l, including RNA, 1 M sodium
acetate/acetic acid buffer (pH 3.5, 4.0, 4.5 or 5.0) and 1
M sodium nitrite solution (final concentrations) at 50, 60
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Figure 1. Deamination treatment and deamination sequencing (NOseq) output. (A) Reaction of adenosine, N6-methyladenosine (m6A) and guanosine
under deamination treatment and their corresponding reaction products inosine, N6-methyl-N6-nitrosoadenosine (NOm6A) and xanthosine. (Supplement
Figure S1 for cytidine and uridine). (B) Deamination treatment of a 53mer, containing m6A at position 33, with 72 different conditions (composed of
different reaction temperatures, pH and reaction times) (Supplement Figure S4 for additional information). (C) Partial deamination sequencing output
and required alignment adaptations (Example: native adenosine residues gave rise to either A or G signals, the latter deriving from the fraction having
undergone deamination to I).




or 70◦C for 1, 3, 5, 10, 20 or 30 min. The reaction was
stopped by adding 0.5 M ammonium acetate solution (final
concentration) and 1 l glycogen (Thermo Scientific) to a
final volume of 250 l. By adding 750 l ethanol (−80◦C)
the treated RNA was ethanol precipitated for 1 h at –80◦C.
Samples were centrifuged for 45 min at 5◦ and 15 000 ×
g. Pellets were washed with 80% ethanol and centrifuged
again. Then, the ethanol precipitation step was repeated.
Pellets were resuspended with 10 l MilliQ water.
Deamination with diethylene glycol dinitrite. Diethylene
glycol dinitrite was synthesized in analogy to a known pro-
cedure (52) as follows. A mixture of diethylene glycol (54
g; 0.5 mol), sodium nitrite (69 g; 1.0 mol) and ice (100 g)
was placed into a one-liter glass beaker. Conc. hydrochloric
acid (101 g; 0.5 mol) was added dropwise under vigorous
stirring and cooling with an ice bath so that the reaction
temperature did not exceed 5◦C. Afterwards, the reaction
mixture was stirred for 5 min and then transferred to a sepa-
rating funnel. The organic layer was separated, washed with
diluted aq. potassium carbonate and dried with potassium
carbonate to give 34.4 g (42%) of the title product as a yel-
low oil. 1H NMR (400 MHz, CDCl3):  = 3.77 (m, 4H, 2 ×
CH2), 4.86 (m, 4H, 2 × CH2) ppm. 13C NMR (125 MHz,
CDCl3):  = 67.2, 69.3 ppm.
Synthetic RNA was deaminated by incubation in an
aqueous solution containing 1 M diethylene glycol dinitrite,
2 M pyridine and 1 M potassium thiocyanate (final concen-
trations) for 2, 5 or 10 h at 37◦C. The solution was diluted
with buffer (10 mM Tris pH 7.4, 300 mM sodium chloride,
1 mM ethylenediaminetetraacetic acid) and the RNA was
precipitated by addition of three volumes of cold ethanol
and incubation in liquid nitrogen for 15 min. After centrifu-
gation and washing with 75% ethanol, the pellet was resus-
pended in MilliQ water, and the integrity of the RNA was
checked by analytical PAGE (stained by SYBR gold).
LC-MS
LC-MS/MS analysis was used to monitor the deamina-
tion levels of treated RNA samples. Prior to LC-MS/MS
analysis, RNA samples (were digested into nucleosides ac-
cording to the following protocol: samples were incubated
in a buffer of 25 mM ammonium acetate (pH 7.5), 0.3 U
nuclease P1, 0.1 U snake venom phosphodiesterase, 1 U
fast alkaline phosphatase and 10 U Benzonase overnight
at 37◦C. The digested samples were analysed on an Ag-
ilent 1100 HPLC series equipped with a diode array de-
tector (DAD) and an Agilent 1100 mass selective detector
(LC/MSD-Trap). A YMC Triart C18 column (S-3 m/12
nm, 120 Å, column size: 150 × 3.0 mm I.D.) from YMC
Europe (Germany) was used at 30◦C column temperature.
Mobile phase A (MPA) consisted of 5 mM ammonium ac-
etate buffer adjusted to pH 5.4 using acetic acid and mobile
phase B (MPB) of pure acetonitrile. The elution was per-
formed at a flow rate of 0.4 ml/min using the following gra-
dient: 3% MBP from 0 to 3 min, 3–15% MPB from 3 to 30
min, 15–90% MPB from 30 to 31 min, 90% MBP from 31 to
35 min, 90–3% MPB from 35 to 36 min and 3% MPB from
36 to 45 min. The effluent from the column was measured
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Table 2. DNA oligonucleotides for amplicon sequencing (purchased from IBA Lifesciences, Germany and Biomers, Germany)
Name Sequence
Malat1 RT primer 5′-AGACGTGTGCTCTTCCGATCTNNNNNNNTGCTAGTCCTCAGGA-3′
Malat1 P5 primer 5′-AATGATACGGCGACCACCGAGATCTACACACACTCTTTCCCTACACGACGCTCTTCC
GATCTAAGATCAAGAGTAAT-3′
18S RT primer 5′-AGACGTGTGCTCTTCCGATCTNNNNNNNCCTTCCGCAGGTTCA-3′
18S P5 primer 5′-AATGATACGGCGACCACCGAGATCTACACACACTCTTTCCCTACACGACGCTCTTCC
GATCTGACGGTCGAACTTGA-3′
H RT primer 5′-AGACGTGTGCTCTTCCGATCTNNNNNNNCATATTCTTATTGCA-3′
H P5 primer 5′-AATGATACGGCGACCACCGAGATCTACACACACTCTTTCCCTACACGACGCTCTTCC
GATCTCGGCCCGCCGTGTGT-3′
fl(2)d RT primer 5′-AGACGTGTGCTCTTCCGATCTNNNNNNNGTTTTGCTCGTATTT-3′
fl(2)d P5 primer 5′-AATGATACGGCGACCACCGAGATCTACACACACTCTTTCCCTACACGACGCTCTTCC
GATCTGTCGCTGCAATGACT-3′
photometrically at 254 nm by the DAD for the detection
of the nucleosides. In addition to the UV detection, a mass
spectrometer was used for the identification of nucleosides,
e.g. N6-methyl-N6-nitrosoadenosine (NOm6A). Mass spec-
trometer settings used included ion polarity: positive; ion
Source: ESI; dry temp: 350◦C; nebulizer: 15 psi; dry gas:
12 l/min; trap drive: 43.0; Octapole RF amplitude: 140.3
Vpp; capillary exit: 96.6 V; skimmer: 40.0 V; Oct 1 DC:
12.0 V; Oct 2 DC: 1.7 V; scan range: 105–600 m/z; aver-
ages: two spectra; maximum accumulation time: 200 ms;
and ICC target: 30 000. Data was analysed with Bruker LC-
MS data reading software (DataAnalysis) and nucleosides
were monitored by multiple reaction monitoring (dynamic
MRM mode).
Library preparation and sequencing
Synthetic oligonucleotide. Around 500 ng of (treated) syn-
thetic RNA oligonucleotide (Table 1) were used as starting
material for library preparation. This includes all synthetic
oligonucleotide samples, used directly as delivered, mixed
or immunoprecipitated before library preparation. First,
a two-step end-repair was performed, combining 5′- and
3′-dephosphorylation (Antarctic Phosphatase) and subse-
quent 5′-phosphorylation (Polynucleotide Kinase PNK),
according to the manufacturer’s instructions (New England
Biolabs) and with addition of an RNase inhibitor (RNase-
OUT, Invitrogen). The end-repaired RNA was purified with
RNeasy MinElute Cleanup kit (Qiagen), using a larger
quantity of ethanol to recover smaller RNA fragments. Li-
brary preparation was then prepared following the NEB-
Next Small RNA Library kit for Illumina (New England
Biolabs): after ligation of the first adapter at the 3′-end of
the end-repaired RNA, the reverse transcription primer was
hybridized, followed by the second adapter ligation at the
5′-end of the RNA. The reverse transcription (RT) was per-
formed, using ProtoScript II (in general) or SuperScript IV
(for RT test––Supplement Figure S11), during 1 h at 50◦C,
according to the manufacturer’s manual, directly followed
by polymerase chain reaction (PCR) employing LongAmp
Taq polymerase during 15 cycles at a primer annealing tem-
perature of 62◦C. The indexing of the samples takes place
at this step: a P7 primer was chosen among the 48 differ-
ently barcoded primers from the NEBNext Multiplex Small
RNA Library Prep Set for Illumina (New England Biolabs).
The P7 and P5 primer allow amplification of the templates
and implementation of the necessary sequences for Illumina
sequencing. A final clean-up and size selection step were
performed to purify the library, applying the GeneJet PCR
kit, according to the supplier’s instructions.
Amplicon sequencing with biological samples. Around 500
ng of (treated) RNA (messenger or total RNA) were incu-
bated at 75◦C for 5 min with 2.5 M of targeted RT primers
(Table 2). Reverse transcription was performed, using 10 U
ProtoScript II (New England Biolabs) in addition with 0.5
mM dNTP mix, 10 mM DTT, 0.4 U RNase inhibitor, 1x
ProtoScript II Buffer (final concentrations) and MilliQ wa-
ter for 2 h at 50◦C. Then, polymerase chain reaction (PCR)
was performed by mixing 5 U of LongAmp Taq DNA Poly-
merase (New England Biolabs) with 0.4 M of targeted P5
primer (Table 2) and 0.4 M P7 primer from the NEB-
Next Multiplex Small RNA Library Prep Set for Illumina
(New England Biolabs) in addition to 300 mM dNTP mix,
1x LongAmp Taq Reaction Buffer (final concentrations)
and MilliQ water. PCR was performed for 25 cycles at a
primer annealing temperature of 50◦C. The amplicon ob-
tained was analysed via 10% denaturing polyacrylamide gel
electrophoresis for 40 min at 10 W. The corresponding gel
area (amplicon size), determined by GeneRuler Low Range
DNA Ladder (Thermo Scientific), was cut out and eluted.
The gel elution was performed overnight at 25◦C in 0.5 M
ammonium acetate solution, followed by Nanosep filtering
(0.45 m, VWR) and subsequent ethanol precipitation.
DNA library quantification and quality control. DNA li-
braries were quantified using the Qubit dsDNA HS (High
Sensitivity) Assay Kit with the Invitrogen benchtop fluo-
rometer Qubit 2.0. Each library (amplicon and synthetic
oligonucleotide) was analysed, and quality evaluation by
automated electrophoresis on the Agilent 2100 Bioanalyzer
system was performed, following the Bioanalyzer High Sen-
sitivity DNA Kit instructions.
Sequencing method. Libraries were subjected to high-
throughput sequencing using an Illumina MiSeq instru-
ment with single-read (SR50) or paired-end (PE75) mode.
Prior to loading on the sequencing chip, the multiplexed li-
braries were diluted to 6–8 pM final concentration.
miCLIP. miCLIP was performed as described previously
(16) using 10 g of purified mRNA from Drosophila
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melanogaster S2R+ cells and 5 g of anti-m6A antibody
(Synaptic Systems). Immunoprecipitations were performed
in quadruplicates and as a control one immunoprecipita-
tion was performed where UV-crosslinking was omitted. Of
note, this sample produced a library of limited complex-
ity, reflecting a low amount of background mRNA bind-
ing. Briefly, total RNA was isolated using Trizol reagent (In-
vitrogen) and DNA was removed with DNase-I treatment
(NEB). Polyadenylated RNA was purified by two rounds of
binding to Oligo (dT)25 magnetic beads (NEB) and frag-
mented with RNA fragmentation solution (Ambion) using
1 l of solution per 2 g of mRNA and with 7 min in-
cubation at 70◦C. Immunoprecipitation was performed at
4◦C in 500 l of binding buffer (BB) (50 mM Tris–HCl
pH 7,4, 150 mM sodium chloride, 0,5% NP-40). First, iso-
lated mRNA and antibody were incubated for 2 h. Sam-
ples were then transferred to individual well of a 12-well
cell culture plate and crosslinked on ice (two-times at 150
mJ/cm2). Next, 60 l of magnetic ProteinG beads (Invitro-
gen) were resuspended in 500 l of BB and added to the IP
sample. Samples were then incubated for additional 2 h at
4◦C, before washing with ice-cold solutions was performed:
1× with BB, 2× with high salt buffer (50 mM Tris–HCl pH
7,4, 1 M sodium chloride, 1% NP-40, 0,1% sodium dodecyl
sulfate), 1× BB, 2× with PNK buffer (20 mM Tris–HCl pH
7,4, 10 mM magnesium chloride, 0,2% Tween). All washes
were performed by gentle pipetting and with 1 min incu-
bation on ice. Washes with HSB were additionally rotated
for 2 min at 4◦C. Finally, beads were resuspended in 900 l
of PNK buffer. 40 l were used for WB analysis to evalu-
ate immunoprecipitation efficiency. Remaining 860 ml were
used for library preparation. All steps of library prepara-
tion were performed as previously described in Sutandy et
al. (53). Libraries were amplified with 17 PCR cycles and
sequenced on a NextSeq500 with a read length of 120 bp,
single end (Table 3).
Bioinformatic analysis
NOseq alignment. NOseq Illumina output demultiplexed
FastQ files were unzipped. The nucleotide sequences
(FASTA format), read information (identity number) and
their corresponding quality scores (encoded in ASCII) were
extracted, compiled and analysed using Python. The bioin-
formatic pipeline is single file dependent and each file is
associated to a reference sequence. Prior to the alignment
of the reads, the whole reference sequence was divided into
smaller overlapping segments with identical size (k-mer of
size k = 11 per default) and indexed by starting position. In
order to increase the algorithm speed, k-mers were alpha-
betically ordered. The alignment process is relying on seed-
and-extend strategy. Sequenced reads were individually seg-
mented into k-mers of size k, scanned against the refer-
ence sequence k-mers and scored according to the asymmet-
ric substitution matrix (Supplement Figure S5). In case of
matching seeds, the alignment was then extended as well as
the score associated. Regarding the +1/−1 reward/penalty
system and by allowing mismatches according to partial
deamination (Figure 1), only the reads with a score equal
to their length were kept. Furthermore, in order to avoid
shifting of the reading frame, sequencing errors and to have
a homogeneous coverage, only reads starting at the first nu-
cleotide of the reference sequence were selected for further
evaluation. In addition, this strict selection process is ap-
plied in order to limit the occurrence of NGS errors within
the short sequencing reads (54). Finally, the totality of per-
fectly aligned reads was used for alignment analysis.
NOseq data analysis. From the aligned reads, the number
of adenosine (A), cytidine (C), guanosine (G) and thymi-
dine (T) was summed for each position and corresponding
frequencies were plotted using matplotlib python library. In
addition, only A positions in the reference sequence were se-
lected and associated A and/or G rates were plotted. From
this analysis, the cumulative density function of the normal
distribution was calculated for each A position using the
python package scipy.stats.norm and plotted together with
the detection threshold at 0.95 (red line) (see Figure 2 as ex-
ample). Above this limit, 5% of the most distant A rates to
the overall distribution was observed, highlighting A sites
with a high probability to behave differently to the other
positions, i.e. presenting m6A candidate sites under deami-
nation conditions.
NOseq UMI assessment. NOseq data were analysed in
order to determine the read redundancy by assessment
of the unique molecular identifiers (UMI). The UMI se-
quence (7 nt) of every aligned read was determined and the
dataset was checked for duplicates (reads with same UMI
sequences).
miCLIP data analysis. miCLIP Data analysis was per-
formed as previously described in Linder et al. (16).
RESULTS
Screening of deamination conditions by LC-MS and sequenc-
ing
In order to distinguish m6A from unmethylated adenosines
in sequencing data, the major step was the conversion of
adenosines into inosines to change the base-pairing prop-
erties in reverse transcription. According to reports about
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Figure 2. General analysis pipeline of NOseq data (exemplary for deamination of the 53mer with a treatment of 50◦C, pH 4.0 and 20 min). After deam-
ination treatment the treated RNA is used for library preparation and sequenced (for comparison to two-step alignment - see Supplement Figure S17).
(A) Reads are aligned to the reference with an asymmetrical substitution matrix (see Supplement Figure S5) to address partial deamination and the cor-
responding fraction of reads in % is plotted for each position in an alignment plot (A in green, G in orange, C in blue and T in red). (B) Adenosine sites
are filtered from the alignment plot. (C) The fraction of reads in % is separated to generate adenosine and guanosine rate plots (separated adenosine and
guanosine fraction of reads in % at A sites). (D) The A rate is then used for evaluation of the m6A site in a probability plot, which illustrates the probability
of an A site being an m6A, calculated by the distance of the respective A rate to the average A rate, with a red line at 0.95 showing the detection threshold.
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adenosine deamination by nitrous acid (43), we set up a
deamination protocol for RNA and performed a condi-
tion screening with a synthetic 53mer containing m6A at
position 33 (Table 1). After optimizing a range of temper-
ature, incubation time and pH values, we identified con-
ditions leading to complete deamination of RNA (70◦C,
pH 3.5, 60 min), as analysed by RP18 chromatography.
Deamination included all exocyclic, primary amines, thus
converting adenosines to inosines, cytidines to uridines,
and guanosines to xanthosines (X) (55) in the process
(Figure 1A and Supplement Figure S1). Using LC–MS,
we detected, in addition to the above, a peak with an
m/z = 311, indicating partial formation of N6-methyl-N6-
nitrosoadenosine (NOm6A) from m6A (44) to a maximum
of 50–70% (Supplement Figure S2). The deaminated syn-
thetic RNA template was then subjected to library prepa-
ration and first sequencing attempts. Thereby we expected
a change in base-pairing properties for all deaminated
and converted nucleotides, with unknown properties for
NOm6A (Supplement Figure S3). In the process of opti-
mizing cDNA synthesis by reverse transcription and library
preparation, it turned out that RNA degradation under
the acidic deamination conditions rendered subsequent Il-
lumina sequencing impracticable. However, by screening a
set of in total 72 deamination conditions, resulting from
permutation of different reaction temperatures, incubation
times and pH values (Table 1, Figure 1B), we identified
a deamination treatment that allowed successful library
preparation and sequencing of the synthetic RNA template
(Supplement Figure S4). A range of conditions leading to
partial deamination of RNA could be determined (with A-
to-I conversion between 10% and 50%), within which the
sequencing output was optimized in terms of aligned reads
and m6A signal strength, i.e. the data were evaluated for the
fraction of aligned reads and maximum m6A signal inten-
sity. Importantly, partial deamination prevented the use of
conventional alignment algorithms. As shown in Figure 1C
(and Supplement Figure S3), native adenosine residues gave
rise to either adenosine or guanosine signals, the latter de-
riving from the fraction having undergone deamination to
inosine. Similarly, cytidines yielded cytidine or thymidine
signals, respectively. At guanosine positions in the reference
sequence, the analysis yielded a vast majority of guanosine
signals, with a small remainder of adenosine. Of note, only
native m6A produced unaltered adenosine signals. These
observations and the associated need for deliberately am-
biguous alignments due to partial deamination required a
specific alignment algorithm, since conventional mapping
tools did not offer this capability.
Alignment and analysis of NOseq data
To enable effective mapping of reads, from what we termed
NOseq, an adapted mapping algorithm using a seed-and-
extend strategy based on local alignment (46) was devel-
oped. At the core of this algorithm was a substitution
matrix composed of score values that reward or penal-
ize alignment options. We adapted these values to account
for the possibility of mapping guanosine and adenosine
onto any purine in the reference genome, and of thymi-
dine (or uridine, respectively) onto any pyrimidine, as de-
picted in Supplement Figure S5. We obtained an align-
ment plot, showing the fraction of respective nucleotides
for each position mapped along the reference sequence
(Figure 2A). The samples were analysed by the degree of
A-to-I conversion, expressed as the fraction of decreased
adenosine and increased guanosine signals at adenosine
(and prospective m6A) sites (Figure 2B). In all but the
weakest and strongest deamination conditions, the m6A33
showed the highest adenosine and lowest guanosine (A-to-
I deamination) signals. For further analysis we separated
the adenosine and guanosine fractions into two individ-
ual plots, showing the adenosine and the guanosine rate
respectively (Figure 2C). Using only reads that cover the
entire sequence under investigation, the distance of the A
rate (at each position) from the mean deamination yield
(mean A rate) was used to identify potential m6A candi-
dates. Thereby a conventional probability plot was applied
to highlight positions with a signal, significantly different
from other adenosine sites (Figure 2D). The m6A signal
strength was then used to identify optimal parameters. In
general, the weakest deamination conditions were not suf-
ficient to achieve a distinction between A and m6A, and
the strongest conditions led to non-informative data out-
put, similar to non-deamination of the templates, although
LC-MS analysis clearly documented near-complete deami-
nation (Supplement Figure S6). We hypothesized that the
product of the slowest deamination reaction, namely the
guanosine-to-xanthosine conversion, might interfere with
the RT-based amplification step, thus selecting exclusively
those few RNA molecules that have escaped deamination.
This hypothesis was confirmed by primer extension exper-
iments on a synthetic RNA fragment, which showed, that
xanthosine residues indeed significantly slow down and par-
tially block reverse transcription (Supplement Figure S7).
Given that each RNA contains an individual number of
guanosine residues, we considered the possibility that op-
timal deamination strength might vary among different se-
quences under investigation. However, our follow-up exper-
iments for target-specific evaluation of m6A sites by ampli-
con sequencing to investigate biological templates (vide in-
fra), revealed that m6A sites can be detected in different se-
quence contexts with the same deamination treatment and
analysis pipeline, without additional optimization steps. A
probable explanation is that under the milder conditions
used, the xanthosine blockage plays a minor role, since the
guanosine conversion is slower in comparison to those of
cytidine and adenosine (Supplement Figure S6). Therefore,
the probability for multiple guanosine-to-xanthosine deam-
ination events are indeed very low, even in G-rich stretches,
and such species do not significantly contribute to the over-
all sequencing output. This assumption was also supported
by our data on the synthetic oligo with multiple G-rich
stretches (Supplement Table S1).
m6A detection and threshold determination
To evaluate the sensitivity of our method and address its
detection threshold for sub-stoichiometric m6A levels at bi-
ological m6A sites, we performed a calibration by analysing
the m6A signal in the same synthetic 53mer, now with an
m6A content at position 33 (m6A/A) that was varied from
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Figure 3. NOseq data comparison (MeRIP enriched vs. non-MeRIP) to
address its detection threshold for sub-stoichiometric m6A with an m6A
content at position 33 (m6A/A) of the 53mer that was varied from 0 to
100%. (black dots MeRIP, grey triangles non-MeRIP). Data was averaged
from duplicates (error bars show standard deviations). Red line shows de-
tection threshold at 0.95.
0 to 100%. Partial deamination parameters (50◦C, pH 4.0,
20 min), representing a compromise featuring optimized
mapping yield versus adenosine deamination, were cho-
sen for this test (Figure 2). Furthermore, decreased for-
mation of NOm6A (not shown) under these milder condi-
tions is thought to avoid potential RT-arrest at m6A sites.
NOseq data showed a statistically valid m6A signal in sam-
ples containing down to ∼50% m6A. This de novo detection
limit could be lowered to ∼10% by conducting a methy-
lated RNA immunoprecipitation (MeRIP) enrichment (56)
prior to NOseq (Figure 3). Such detection on the basis of
antibody-enriched RNA fragments was tested with regard
to application of NOseq on low-abundant RNA species as
mRNA. Expectedly, the linear dependence of m6A signal
to m6A content is lost as a consequence of this enrichment
step. The m6A signal in MeRIP-enriched RNA sequences
therefore does not allow any conclusions to be drawn about
the methylation level. However, once detected, a quantifi-
cation of the m6A site in a subsequent step by using a se-
ries of mixtures of synthetic oligos with defined amounts
of m6A seems practicable. Of such a calibration series, we
determined the A signal at the m6A site in the deaminated
calibration samples and put it into relation to the respective
m6A content. Given the clearly linear correlation (Supple-
ment Figure S8), we conclude that quantification of m6A
sites might, in principle, be possible in a two-step procedure,
where the first step must identify the position in a detection
step, and the second step would require sequence-specific
calibration for quantitative analysis. However, in contrast to
straightforward validation of m6A in amplicons (vide infra),
such a calibration would have to rely on synthetic modified
RNA, and require considerable effort in terms of time and
resources.
Investigation and validation of biological m6A sites by ampli-
con sequencing
We applied NOseq to five biological m6A sites to demon-
strate the applicability of the method. To this end, we de-
veloped an amplicon sequencing method for target-specific
Figure 4. Library preparation scheme for amplicon sequencing of targeted
m6A sites. The target region is amplified in a two-step process. First, reverse
transcription of the deaminated RNA is performed with a target-specific
RT primer. The latter contains the UMI and the binding sequence for the
universal P7 primer including the barcode for Illumina sequencing. Af-
terwards, a target specific P5 primer and the P7 primer are used for PCR
amplification.
evaluation of m6A sites (Figure 4). Of note, library prepa-
ration for the above calibration with synthetic RNA was
based on an adapter ligation, while biological samples re-
quired the design of targeted primers, compatible with the
Illumina sequencing technology, for each m6A site un-
der investigation. In a two-step process, including reverse
transcription and PCR amplification, sequencing libraries
were prepared. To address partially deaminated RNA tem-
plates, we also tested primers with complementary degen-
erated target sequences. The extended binding possibilities
yielded unspecific sequence amplification (not shown) and
this strategy was therefore not further pursued. Rather, as
a compromise of signal-to-noise versus sequencing output,
we turned to conventional primers and used milder deami-
nation conditions (60◦C, pH 5.0, 10 min, Supplement Fig-
ure S9), thus obtaining sufficient PCR product for RNA-
Seq. Assessment of unique molecular identifiers (UMIs) in
typical amplicons (Supplement Figure S13 and Supplement
Table S1) revealed an average read redundancy around 10%
(Supplement Table S2), showing the samples to be represen-
tative and essentially free of significant PCR-amplification
bias.
An initial experiment was targeted at the highly abun-
dant and well-described m6A site at position 1832 in hu-
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Figure 5. Adenosine rate (A fraction of reads in % at A sites) and probability plots of three biological amplicons, showing the progressed A-to-I conversion
and corresponding m6A site evaluation (red line shows detection threshold at 0.95). (A) m6A at position 1832 in human 18S rRNA (HEK293T cells). (B)
m6A at position 2577 in human lncRNA MALAT1 (HeLa cells). (C) m6A at position 349 in Drosophila melanogaster H mRNA after MeRIP enrichment.
(Supplement Figures S14 & 15 for additional information, including non-treated references).
man 18S rRNA (57). Under the selected conditions we were
able to clearly distinguish and detect the m6A site from the
surrounding A sites (Figure 5A). Of note, plotting C-to-
U (T-rate) and A-to-I (G-rate) changes across the ampli-
con sequence revealed a uniform distribution of deamina-
tion events, including the direct proximity to the m6A tar-
get (Supplement Figure S15). This demonstrated that the
use of conventional primers did not incur deamination bi-
ases in the amplicon.
Without changes, these conditions for target-specific
evaluation of m6A sites were subsequently applied to other
m6A positions in different sequence contexts. As another
m6A site for evaluation, the m6A at position 2577 in the
human lncRNA MALAT1 was analysed. Again, the same
conditions led to clear distinction between m6A and the sur-
rounding A sites (Figure 5B). From the clear signals with-
out prior MeRIP enrichment, the occupancy of the sites in
rRNA and lncRNA was gauged to exceed 50% (determined
detection threshold – Figure 3), which is in keeping with val-
ues obtained by other methods (57). As third validation, we
applied NOseq in combination with MeRIP (56) to scruti-
nize m6A candidate sites in mRNA from D. melanogaster.
The first investigated m6A candidate site was selected at
position 349 in the 5′-untranslated region (UTR) of the
protein-coding mRNA Hairless (H) in D. melanogaster,
which plays a role in Notch signalling (58). This candidate
site produced a strong signal in miCLIP experiments (Sup-
plement Figure S10a) and was thus validated by NOseq as
genuine m6A site (Figure 5c). Finally, a further validation
was conducted on a sequence region comprising two m6A
candidate sites drawn from miCLIP experiments (Supple-
ment Figure S10b) in the coding sequence of the mRNA
female-lethal-2-d (fl(2)d) in D. melanogaster, an associated
component of the methyltransferase complex mediating
m6A methylation (59). Both sites were detected via NOseq.
As an ultimate validation, NOseq signals from these sites
were compared to those obtained with RNA from an Ime4
knockout mutant. We had previously characterized this
knockout of the homolog of mammalian METTL3 protein,
and found mRNA from this mutant to contain drastically
reduced levels of m6A in polyA-RNA (51,60). Correspond-
ingly, neither of the two m6A candidate sites were detectable
by NOseq anymore in the respective amplicon (Supplement
Figure S16), validating the detection of these m6A sites
in mRNA.
DISCUSSION
In summary, we developed an m6A detection approach
based on chemical deamination of RNA. The pre-treatment
with sodium nitrite in an acidic milieu and under heat in-
fluence enables discrimination of adenosines and m6A in
RNA-Seq data. Chemical deamination of adenosines leads
to a conversion to inosines and therefore to a certain num-
ber of guanosine signals in sequencing due to changes in re-
verse transcription properties. However, treatment does not
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lead to altered sequence information at m6A sites, which
can hence be identified by lack of deamination products,
corresponding to a high A rate, at a given position. Be-
cause xanthosine as a deamination product of guanosine
effectively blocks reverse transcription, we had to resort to
partial instead of complete deamination, as is known from
bisulfite sequencing. Therefore, the method is not yet suit-
able for transcriptome-wide studies, but might be thus de-
veloped, if the xanthosine block can be overcome. One op-
tion could be a polymerase variant that bypasses xantho-
sine with higher efficiency. However, given that we already
tested other RT enzymes, specific engineering or in vitro
evolution might be necessary (32). Our method allows ex-
change of the RT enzyme without further adaptations (Sup-
plement Figure S11). In this perspective, we have also suc-
cessfully applied an organic nitrite as less acidic nitrosyla-
tion reagent (diethylene glycol dinitrite), with results simi-
lar to nitrous acid, but with decreased degradation (Supple-
ment Figure S12). The detection of m6A sites with differ-
ent methylation levels is possible, and the detection limit of
the method can be further reduced by enrichment of m6A
fragments with m6A-specific antibodies prior to the treat-
ment, whereby even adenosines with very low methylation
level (about 10%) can be differentiated.
A quantification of methylation stoichiometry in m6A
sites subsequent to their validation by NOseq is made plau-
sible by our proof-of-principle data on synthetic RNA.
This would comprise synthetic template mixtures with as-
cending m6A content in the sequence context in question.
The sequence-specific calibration differentiates the proce-
dure from known methods (17). While plausible, it would
admittedly require major efforts and an individual calibra-
tion for every m6A site in its particular sequence context.
However, if corresponding calibration repetitions in differ-
ent sequence contexts were producing consistently linear
correlations, that might plausibly allow a transfer and ap-
plication of linear calibrations (such as shown in Supple-
ment Figure S8) from bona fide sites to new sites in ques-
tion, and thus eliminate the need for subsequent sequence-
tailored validations. However, the number of such analyses
required for sufficient confidence is well outside the scope
of this work.
Importantly, we here prove the applicability of our
amplicon-based detection in as many as five biological
m6A sites, two of them previously known, namely in hu-
man 18S rRNA and lncRNA MALAT1. Importantly, the
other three led to validations of new sites in mRNA from
Drosophila melanogaster. We anticipate that this approach
will find application in the RNA research field by allow-
ing site-specific m6A evaluation in various organisms and
RNA species. In our experience, the method is easy to ap-
ply, and the specific primer target sequences can be easily
adapted for other m6A sites under investigation (Supple-
ment Figure S13). The required sequencing depth is rather
low, with verified m6A detectability in our amplicon exper-
iments based on a few hundred reads. Given a designed
amplicon, an assay with modest requirements for exper-
imental skills is readily established and enables straight-
forward comparative assessment of RNA samples in large
numbers.
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SLor, CNRS-Université de Lorraine-INSERM, Nancy,
France) for excellent technical assistance in Illumina MiSeq
sequencing, the IMB Core Facility Genomics for their help-
ful support and use of its Illumina NextSeq machine (INST
247/870–1 FUGG), and Anke Busch from the IMB Core
Facility Bioinformatics for analyses of miCLIP data. We
want to further thank Dr. Lyudmil Tserovski for his con-
tributions during early stages of this project.
Author contributions: M.H. designed the study. S.W. and
A.G. designed and performed experiments and interpreted
the data. A.G. created and performed the bioinformatic
analysis pipeline. F.P. and T.K. contributed to the bioin-
formatic analysis. V.M. and Y.M. performed RNA-Seq.
T.L., J.K. and J.-Y.R. performed miCLIP and delivered
Drosophila melanogaster stocks. M.V.S. and C.H. delivered
data on xanthosine and performed experiments with diethy-
lene glycol dinitrite. A.H., J.-Y.R., T.L., J.K., Y.M., V.M.
and C.H. contributed to the paper with helpful discussions
and proofreading of the paper. S.W., A.G. and M.H. wrote
the article. M.H. supervised the work.
FUNDING
Deutsche Forschungsgemeinschaft (DFG) [HE3397/17-1,
RO4681/6-1, RE4193/1-1 to M.H./J.-Y.R., HO 4436/2-2
to C.H., KO4566/3-2 to J.K., SPP1784]; FRCR EpiARN
project from Grand Est Region, France (to Y.M.) and was
performed in the framework of the EPITRAN COST initia-
tive [CA16120]. Funding for open access charge: Johannes-
Gutenberg University Mainz.
Conflict of interest statement. None declared.
REFERENCES
1. Nachtergaele,S. and He,C. (2018) Chemical modifications in the life
of an mRNA transcript. Annu. Rev. Genet., 52, 349–372.
2. Zaccara,S., Ries,R.J. and Jaffrey,S.R. (2019) Reading, writing and
erasing mRNA methylation. Nat. Rev. Mol. Cell Biol., 20, 608–624.
3. Huang,H., Weng,H. and Chen,J. (2020) m6A modification in coding
and non-coding RNAs: roles and therapeutic implications in cancer.
Cancer Cell, 37, 270–288.
4. Xiao,W., Adhikari,S., Dahal,U., Chen,Y.-S., Hao,Y.-J., Sun,B.-F.,
Sun,H.-Y., Li,A., Ping,X.-L., Lai,W.-Y. et al. (2016) Nuclear m6A
reader YTHDC1 regulates mRNA splicing. Mol. Cell, 61, 507–519.
5. Fustin,J.-M., Doi,M., Yamaguchi,Y., Hida,H., Nishimura,S.,
Yoshida,M., Isagawa,T., Morioka,M.S., Kakeya,H., Manabe,I. et al.
(2013) RNA-methylation-dependent RNA processing controls the
speed of the circadian clock. Cell, 155, 793–806.
PAGE 11 OF 12 Nucleic Acids Research, 2021, Vol. 49, No. 4 e23
6. Zheng,G., Dahl,J.A., Niu,Y., Fedorcsak,P., Huang,C.-M., Li,C.J.,
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